Emerging Healthcare Solutions executes Term Sheet with Stand-By Systems

Emerging Healthcare Solutions, Inc. (Pink Sheets: EHSI) disclosed today that the Company has executed a Term Sheet with Stand-By Systems. The Term Sheet represents successful negotiations between the two companies just ahead of finalizing a Definitive Agreement. Stand-By Systems (SBS) owns the FDA approved SBS 1615 catalytic oxygen generator and associated systems. This cutting edge generator provides medical grade USP oxygen at the push of a button from self-contained inert dry compounds. Stand-By Systems intends to make this portable personal life-saving device (smaller than the size of a soft drink can) become as common in everyday life as household fire extinguishers, smoke detectors and first-aid kits. The Term Sheet is pursuant to an option between the two companies that was executed and announced on May 10^th.

According to the American Heart Association, 87.5 million Americans are at risk of heart attack or stroke with the critical need for oxygen even before 911/EMS can respond. Stand-By System's research leads the company to believe that the critical-need domestic market could translate into a multibillion dollar business.

The first of several oxygen delivery systems using the SBS 1615 catalytic oxygen generator is called LIFEDGE®, which is scheduled for pilot scale production. LIFEDGE® is a lightweight, on demand dispenser of emergency-duration medical grade oxygen, created by the SBS 1615 catalytic oxygen generator. There is no other technologically equivalent product available today. The LIFEDGE® prototype is complete and is trademarked and protected by multiple patents.

Another Stand-By Systems product for use with the SBS 1615 catalytic oxygen generator is the MAYDAY®, which is an emergency personnel escape system (self-contained breathing apparatus). The MAYDAY® is expected to replace technologically obsolete devices currently deployed within the military, in sensitive governmental installations and in industrial plants.

Emerging Healthcare Solutions focuses on the development of profitable emerging medical technology, a sector that also includes Johnson & Johnson (NYSE: JNJ), Human Genome Sciences, Inc. (NASDAQ: HGSI), Novartis (NYSE: NVS) and GlaxoSmithKline (NYSE: GSK).